of 27.8 years (vs. 35.8 years for the U.S. all races), and Indians and Alaska Natives (AI/AN) experience high rates relatively poor with 32% living below the poverty rate of chronic kidney disease. Several studies have demonstrated (vs. 13.1% of the US population). Unemployment is increased rates of early kidney disease among AI/AN, both in twice as high as and income two thirds of that of the diabetics and non-diabetics. Among some tribes of the Amerirest of the country; the high school dropout rate is 35%
can Southwest, high rates of mesangiopathic glomerulonephritis have been documented. The epidemic of diabetes among compared with 25% for the general population [1] .
AI/AN, which began in the middle of the 20th century, appears
During the past few decades the disease burden among to be driving the increase in end-stage renal disease (ESRD).
AI/AN has shifted from acute infectious diseases to
At the end of 1999, AI/AN had a national prevalence rate of chronic illnesses, particularly type 2 diabetes and its comtreated ESRD that was 3.5 times greater than that of white plications. Diabetes, virtually unknown among AI/AN Americans. There is significant regional variation as well as differences among the approximately 550 tribes that make up people prior to World War II, is a problem of epidemic the American Indian community, with some tribes experiencproportions among the native people of North America.
ing ESRD rates over twenty times the rate of whites. Although Diabetes prevalence among AI/AN aged 20 to 44 years, graft survival is excellent, AI/AN ESRD patients are less likely 45 to 64 years, and over 65 years is 3.5%, 19%, and than whites to be placed on the transplant waiting list, and those listed wait longer for a transplant. Despite socioeconomic 21.5%, respectively, 2.8 times the rate of diabetes among barriers and high rates of co-morbid illness, survival among US non-Hispanic whites [2] . Nine percent of all AI/AN AI/AN ESRD patients is better than among whites. The burden aged 20 years and older are diabetic. In some tribes (for of kidney disease, particularly the multigenerational occurexample, Pima, Zuni), 30 to 50% of the population is rence in some families, is perceived as a major threat to the diabetic. Among Navajo people aged over 45 years 40% well-being of native communities. There is a sense of urgency among tribal leaders to address this epidemic, and research are diabetic [3] . The incidence continues to rise among that may decrease its burden is likely to be welcomed. all age groups, but this rise is most alarming in adolescents and young adults. . This is American Indians and Alaska Natives experience high rates of end-stage renal disease (ESRD). At the end of 4.5-, 5.7-, and 21.3-fold higher than that for African Americans, American Indians, and European Ameri-1999, 5361 people identified as AI/AN were being treated for ESRD, reflecting a prevalence 3.5 times greater than cans, respectively. Approximately 2% (100 persons) of the adults aged 21 years and older in the Zuni population that of white Americans [5]. The incidence for ESRD was 2.7 times the white rate and increased at 8% per have treated ESRD. With rates this high, virtually every family has an affected member. year during the period of 1992 to 1996. During the 10-year period from 1988 to 1997 the number of AI/AN Chronic kidney disease with ESRD tripled. The epidemic of diabetes among AI/AN, which began in the middle of the 20th century, End-stage renal disease rates are but one reflection of the burden of kidney disease; the rate of renal disease appears to be driving the increase in ESRD. More than two thirds (68%) of AI/AN who initiated treatment for less than end-stage is more difficult to determine. Several studies have demonstrated increased rates of early kid-ESRD in 1999 developed kidney failure as a result of diabetes, virtually all type 2, while only 25% of whites ney disease among AI/AN, both in diabetics and nondiabetics. The Strong Heart Study, a longitudinal study and 42% of blacks with ESRD were diabetic. The incidence for ESRD due to type 2 diabetes among AI/AN to measure risk factors for cardiovascular disease among American Indians from three geographic sites (Arizona, during 1996 to 1999 (349/million) was three times the white rate (99/million), and higher than any other disNorth and South Dakota, and Oklahoma) has demonstrated high rates of abnormal albumin excretion (20.1 ease-specific rate for any US race. The incidence was substantially higher in AI/AN women (394/million) than in to 48.3%) in all tribes studied [8] . Although the prevalence of diabetes was 53% in the study population, permen (304/million). In addition to those whose primary renal diagnosis is diabetic nephropathy, many persons sons without diabetes also had high rates (10 to 20%) of abnormal albuminuria. Among both diabetics and with ESRD due to non-diabetic kidney disease subsequently develop diabetes. Consistent with the early onnon-diabetics abnormal albumin excretion was associated with increased blood quantum (degree of Indian set of type 2 diabetes among native people, the mean age of onset of ESRD for AI/AN is 57 years, six years heritage), suggesting a genetic basis for susceptibility to renal injury. The Zuni Kidney Project, a populationyounger than for whites (63 years).
The rates cited above describe the burden of ESRD based, cross-sectional survey of the Pueblo of Zuni also has demonstrated albuminuria in 20% of the population, among all persons in the United States identified by their treatment facility as AI/AN. As alarming as these naonly half of whom are diabetic [7] . Determining the burden of non-diabetic renal disease tional rates are, they mask significant regional variation as well as differences among the approximately 550 tribes is problematic in a population where 30 to 50% of the adult population may be diabetic, because many cases that make up the American Indian community. Analysis of 1994 data from ESRD Network #15 and the IHS shows of non-diabetic renal disease also may have diabetes as a co-morbid condition. In these cases nephrologic evaluthat the burden of kidney failure is much higher among AI/AN of the Southwest, who receive their care from ation might be delayed until late in the course of the renal injury, when biopsy is no longer a consideration, IHS, than it is among the US population or the national AI/AN population. ESRD Network #15, which collects and physicians may incorrectly assume that the primary cause of the renal failure is diabetes. data from the Southwest (Arizona, New Mexico, Colorado, Utah, Wyoming, and Nevada), includes more than
The prevalence and natural history of non-diabetic kidney disease among AI of the Southwest has been the 30% of the AI/AN identified in the US Renal Data System (USRDS) database and a plurality of the AI/AN subject of several published reports over the past 20 years. ESRD population had functioning transplants, comshowed cellular crescents [10] . The majority showed interpared with 36% of white US ESRD patients. The rate position of mesangial matrix material into the glomerular of renal transplants for the treated AI/AN ESRD was capillary walls, glomerulosclerosis, interstitial fibrosis, and 0.7 transplants/100 patient-years on dialysis, while the tubular atrophy. Although these reports and anecdotal rate for white patients was 1.8 transplants/100 patientclinical reports suggest high rates of glomerulonephritis years on dialysis. Transplant rates among diabetic ESRD among both the Zuni and other tribes, the Zuni Kidney patients are similarly disproportionate: 0.4/100 patientProject is the first population-based investigation of the years on dialysis for AI/AN and 0.9 for US whites. Acburden of non-diabetic renal disease in an AI/AN comcording to the Health Care Financing Administration munity.
AI/AN ESRD patients are less likely than whites to be The burden of nephropathy among diabetics has been placed on the transplant waiting list, and those listed monitored for several years by the IHS Diabetes Prowait longer for a transplant. Similar results were found gram through a yearly chart audit [11] , which includes in studies by ESRD Network #15 of AI/AN ESRD pameasures of renal function and abnormal protein excretients in Arizona and New Mexico, who have lower transtion. In 1999, 13,248 charts were randomly selected for plant rates than whites in both states, even when rates are audit from the 80,827 persons enrolled in the IHS Diabetes adjusted for diagnosis and age [13] . Delays in completing Registry. Although only 3% of these diabetics had a creattransplant evaluations play a significant role in the low inine greater than two, nearly 50% had significant loss of access to transplantation for at least some racial and renal function based on a calculated creatinine clearance: economic minorities. ESRD Network #15 and the IHS 2% with less than 20 mL/min, 19% with 20 to 59, 22% examined socio-demographic factors, ESRD treatment, with 60 to 80, and 45% with Ͼ80 mL/min. Abnormal co-morbidities, and transplant candidacy status to deterprotein excretion was present in 33% of the patients, mine the factors that contribute to candidacy and whe-10% with microalbuminuria and 23% with overt proteinther the AI/AN ESRD population experiences barriers uria. Hypertension was present in 77% of those with overt not encountered by the white population. Using six difproteinuria and 69% of those with microalbuminuria. ferent criteria, they showed that the rates of candidacy for AI/AN and white ESRD patients were about the same TREATMENT OF ESRD by every definition except the most stringent: awaiting transplant. Thus, AI/AN are referred for transplant at For many tribes, the epidemic burden of ESRD has become a community-wide problem, and significant efsimilar rates as white patients, but experience a greater delay before transplantation. forts have gone into establishing dialysis services on reservations. The first on-reservation dialysis unit was estab-
The major barriers to transplantation for AI/AN ESRD patients lie in the process of fulfilling requirements and lished at Shiprock, New Mexico in 1979. At the end of 2000 there were over 30 dialysis units on or near reservain the availability of matching kidneys. Data obtained from the United Network for Organ Sharing (UNOS) tions serving predominantly AI/AN patients [12] . Although reservation-based dialysis units have improved indicate that the Kaplan-Meier median waiting time to transplant for patients from Arizona and New Mexico the access of patients to renal replacement therapy, enormous barriers to improving care remain. These include listed during 1997 through 1999 was 1306 days for AI/AN and 929 days for whites. After six months on the waiting the rural and frequently isolated settings where travel to facilities is made difficult by distance and road condilist 6.2% of the AI/AN patients and 11.1% of white pa-
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tients had received a transplant. Although a higher proand blood pressure was controlled in 62%: 16% achieved portion of AI transplant recipients in ESRD Network "Ideal BP Control" (Ͻ120/Ͻ80 mm Hg), 22% "Target" #15 have a living-related donor allograft than white recip-BP (120 to Ͻ130/80 to Ͻ85 mm Hg), and 24% "Adeients, cadaver donation from AI/AN remains a rare event.
quate Control" (130/85 to Ͻ140/Ͻ90 mm Hg). ApproxiSignificant cultural barriers will have to be overcome to mately 30% had "Inadequate" control (140/90 to Ͻ160/ increase the donation rate.
Ͻ95 mm Hg) and 8% had markedly poor control (160/ Unlike African Americans, another racial minority 95 mm Hg or higher). In aggregate, blood pressure was with low transplant rates, graft survival in AI/AN comcontrolled in 62% of diabetics compared to 27% of the pares favorably with that of whites. UNOS reports that US hypertensive population. Of the total number of diaboth patient and graft survival were slightly, though not betic patients reviewed, over 80% had a creatinine deterstatistically, better among AI/AN than among whites in mination and urinalysis within the past year, and over Arizona and New Mexico during 1997-1999.
75% had a lipid evaluation. Sixty-three percent of patients with abnormal protein excretion and 73% of persons with abnormal protein excretion and hypertension SURVIVAL WITH ESRD were treated with an angiotensin converting enzyme Despite socioeconomic barriers and high rates of co-(ACE) inhibitor. morbid illness, survival among AI/AN ESRD patients
The effectiveness of the IHS in achieving this level of is better than among whites. The USRDS reports a morcare suggests the potential benefit of approaching kidney tality rate for prevalent dialysis patients in 1999 of 196.7/ disease using a public health model. Such a model in-1000 patient-years for whites and 162.4/1000 patientcludes a multi-disciplinary clinical approach integrated years for AI/AN. Although the mean albumin of AI/AN with community-based interventions. These intervenpersons starting dialysis from 1995 to 2000 (3.0 g/dL)
tions include preventive measures involving environwas lower than for whites (3.2 g/dL), body mass index, mental, educational, and outreach activities, and comwhich also may predict survival, was higher (26.8 kg/m 2 )
bine with the therapeutic measures into a comprehensive than for whites (25.8 kg/m 2 ). Survival among AI dialysis health service delivery system. patients of ESRD Network #15 appears to be better than USRDS rates. Although network-specific mortality rates have not been calculated, virtually all of the facilities FUTURE RESEARCH serving native patients have standardized mortality ratios Even with highly effective intervention programs, the (SMR) of less than 1.0, several with SMRs much lower.
burden of ESRD will continue to increase among AI/AN. In 2001, the SMRs of the six facilities serving the Navajo AI/AN communities are often considered as subject popNation range from 0.37 to 0.94. This was particularly ulations for research because they are relatively easy to remarkable because the mean albumin of all AI/AN identify, have high rates of specific diseases, and are dialysis patients in Network #15 was 2.81 g/dL, 10% highly endogamous. The epidemic of type 2 diabetes that lower than the mean of all Network #15 patients, 3.12 g/dL.
has affected AI/AN communities for 50 years is now being duplicated in other "emerging" groups worldwide and in the populations of highly industrialized countries, PREVENTION/EARLY INTERVENTION suggesting that AI/AN are not an aberrant group but Diabetes is the predominant cause of the excess burmerely "ahead of their time." The natural history of den of ESRD among AI/AN, and the IHS has committed diabetic nephropathy has been well studied in the Pima significant resources over the past 30 years to address Indians and has been utilized in understanding other diabetes and its complications. Despite per capita fundpopulations. Native health leaders frequently express ing of only 40% of what is provided for the US civilian the desire that further efforts will be made to research population through private insurance and other proeffective preventive interventions that will have a similar grams ($1578 vs. $3920/year), the IHS, a public health wide application. agency providing comprehensive care to AI/AN, has Some research questions that could be addressed in been aggressive in implementing and monitoring optimal the near future include: care for diabetics at risk for progressive renal disease.
A review of 13,248 charts randomly selected from the Is there increased susceptibility to non-DM renal in-80,827 persons enrolled in the IHS Diabetes Registry jury among AI/AN? in 1999 demonstrated that IHS providers were more Why is the incidence of ESRD increasing among AI successful in achieving benchmarks of clinical care for women with diabetes? diabetic nephropathy than other large providers [11] . Of Why is survival on dialysis better for AI/AN than for the 13,248 patients reviewed, 67% were hypertensive. Of these, 67% were being treated with an ACE inhibitor; nonAI/AN populations despite low initial albumin?
